Recruiting

Observational Study

Sponsor:

Boston Children's Hospital

Code:

NCT05507320

Conditions

Epilepsy

Eligibility Criteria

Sex: All

Age: 14 - 70

Healthy Volunteers: Not accepted

Interventions

Mechanisms of action perception and execution

Study Details

Brief summary:

Study the mechanisms underlying action recognition and execution

Conditions

Epilepsy

Study ID

NCT05507320

Start date

Sep 1, 2021

Status verified date

Aug, 2022

Completion date

Sep 1, 2025

Anticipated

Primary completion date

Sep 1, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 14 - 70

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients with pharmacologically intractable epilepsy

Exclusion Criteria:

  • Any situation that may put the patient at risk

Study Design

Enrollment

30 participants

Anticipated

Interventions and Outcome Measures

Interventions

Mechanisms of action perception and execution

Study the mechanisms of action perception and execution

Primary outcome measure

  • Selectivity for kinematics and movement type in neurophysiological responses [ Time Frame: Through study completion, an average of 2 years. ]
  • Evoked responses by action execution [ Time Frame: Through study completion, an average of 2 years. ]
  • Evoked responses by action observation [ Time Frame: Through study completion, an average of 2 years. ]

Central Contacts and Locations

Central contacts

Gabriel Kreiman, PhD

6179192530gabriel.kreiman@tch.harvard.edu

Locations

Boston Children's Hospital

Recruiting

Boston, Massachusetts, United States, 02115

Contacts

Dominguez Robleinscky

617-919-2530domingues.robleinscky@childrens.harvard.edu

Gabriel Kreiman

6179192242gabriel.kreiman@tch.harvard.edu

More Information

Sponsor

Boston Children's Hospital

Last update posted

Aug 18, 2022

Last verified

Aug, 2022

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston Children's Hospital on 2022-08-18.